Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Primary Breast Cancer”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Testing effectiveness (Phase 2)Study completedNCT00247650
What this trial is testing

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Novartis 190
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Very early researchEnded earlyNCT04102618
What this trial is testing

A Window-of-opportunity Study of Pelareorep in Early Breast Cancer

Who this might be right for
Breast Cancer
Oncolytics Biotech 26
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Looking for participantsNCT06150898
What this trial is testing

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Who this might be right for
Early-stage Breast CancerEstrogen-receptor-positive Breast Cancer
Jules Bordet Institute 112
Testing effectiveness (Phase 2)Ended earlyNCT00162812
What this trial is testing

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

Who this might be right for
Breast Cancer
Jules Bordet Institute 338
Large-scale testing (Phase 3)UnknownNCT03385200
What this trial is testing

KVUS at Neoadjuvant CTx of Breast Cancer

Who this might be right for
Early Primary Breast Cancer
RWTH Aachen University 60
Testing effectiveness (Phase 2)UnknownNCT00957125
What this trial is testing

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early

Who this might be right for
Breast Cancer
Thomas Hatschek 151
Large-scale testing (Phase 3)Looking for participantsNCT07373782
What this trial is testing

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Universitaire Ziekenhuizen KU Leuven 53
Testing effectiveness (Phase 2)Ended earlyNCT01864798
What this trial is testing

Evaluate Denosumab in Young Patients With Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Jules Bordet Institute 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Not applicableStudy completedNCT05727813
What this trial is testing

To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)

Who this might be right for
Cancer, Treatment-RelatedTumor of BreastSystemic Inflammatory Response+1 more
University of Roma La Sapienza 20
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Large-scale testing (Phase 3)WithdrawnNCT00888082
What this trial is testing

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Who this might be right for
Breast CancerOvarian Function
AstraZeneca 102
Not applicableActive Not RecruitingNCT05926024
What this trial is testing

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 253
Not applicableLooking for participantsNCT06830590
What this trial is testing

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Who this might be right for
Breast CancerMolecular Pathway DeregulationTreatment
Liaquat University of Medical & Health Sciences 300
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Load More Results